StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Other Products by Quarter

Other Products (Cayston, Jyseleca, Letairis, Zydelig) — U.S. sales ($M) ($M)

QuarterlyAnnual

Gilead Sciences Other Products: $22M in Q2 2026, down 50.0% from a year earlier. That is the lowest of the 38 quarters on record here.

Latest, Q2 2026
22
Period ended Jun 30, 2026
Change on a year earlier
-50.0%
44 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
30
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-06) ↗

Reported in Form 10-Q / 10-K Disaggregated Revenue Note & Form 8-K Product Sales Summary.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Products (Cayston, Jyseleca, Letairis, Zydelig) — U.S. sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202622-50.0%Form 10-Q (filed 2026-08-06) ↗
Q1 2026Mar 31, 202639-17.0%Form 10-Q (filed 2026-05-07) ↗
Q4 2025Dec 31, 2025520.0%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 202534-27.7%Form 10-Q (filed 2025-11-07) ↗
Q2 2025Jun 30, 202544-55.1%Form 10-Q (filed 2026-08-06) ↗
Q1 2025Mar 31, 202547-20.3%Form 10-Q (filed 2026-05-07) ↗
Q4 2024Dec 31, 202452-18.7%Form 10-K (filed 2026-02-24) ↗
Q3 2024Sep 30, 202447-31.9%Form 10-Q (filed 2025-11-07) ↗
Q2 2024Jun 30, 202498+53.1%Form 10-Q (filed 2025-08-07) ↗
Q1 2024Mar 31, 202459-4.8%Form 10-Q (filed 2025-05-07) ↗
Q4 2023Dec 31, 202364-73.3%Form 10-K (filed 2026-02-24) ↗
Q3 2023Sep 30, 202369+146.4%Form 10-Q (filed 2024-11-12) ↗
Q2 2023Jun 30, 202364+73.0%Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 202362+138.5%Form 10-Q (filed 2024-05-08) ↗
Q4 2022Dec 31, 2022240+788.9%Form 10-K (filed 2025-02-28) ↗
Q3 2022Sep 30, 202228-17.6%Form 10-Q (filed 2023-11-07) ↗

Cite this data

StockData. (2026). Gilead Sciences Other Products ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/other-misc-us

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.